-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
-
Summary
-
Centessa Pharmaceuticals plc quarterly/annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from Q4 2020 to Q1 2024.
- Centessa Pharmaceuticals plc Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending March 31, 2024 was $2.53M, a 7.89% increase year-over-year.
- Centessa Pharmaceuticals plc annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $9.91M, a 36.1% increase from 2022.
- Centessa Pharmaceuticals plc annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $7.28M, a 391% increase from 2021.
- Centessa Pharmaceuticals plc annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2021 was $1.48M.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Growth (%)